MabVax Therapeutics Holdings Inc (MBVX):企業の財務・戦略的SWOT分析

◆英語タイトル:MabVax Therapeutics Holdings Inc (MBVX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2905
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MabVax Therapeutics Holdings Inc (MBVX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MabVax Therapeutics Holdings Inc (MabVax Therapeutics) formerly known as Telik, Inc. is a clinical-stage biotechnology company that focuses on development of pipeline of human monoclonal antibody products for diagnosis and treatment of cancer. The company’s research and development activities are focused on advancing its clinical advanced drug candidates, under the antibody and vaccine programs. The pipeline product candidates include HuMab-5B1, MVT-5873, MVT-2163 and MVT-1075. The company’s vaccine programs candidates for bivalent vaccine, trivalent vaccine, pentavalent vaccine and multiple vaccines. The company has partnerships with academic institutions and also with pharmaceutical and biotechnology companies. MabVax Therapeutics is headquartered in San Diego, California, the US.

MabVax Therapeutics Holdings Inc Key Recent Developments

Aug 03,2018: Delaware Court of Chancery sets hearing date On petition filed By MabVax Therapeutics
Aug 01,2018: MabVax Therapeutics announces board of director changes
Jul 27,2018: MabVax Therapeutics Files Delaware Petition
Jul 05,2018: MabVax Therapeutics Receives Nasdaq Delist Determination
Jun 27,2018: MabVax Therapeutics Receives Superseding Letter Related to the Late Filing of Form 10-Q

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
MabVax Therapeutics Holdings Inc – Key Facts 6
MabVax Therapeutics Holdings Inc – Key Employees 7
MabVax Therapeutics Holdings Inc – Key Employee Biographies 8
MabVax Therapeutics Holdings Inc – Major Products and Services 9
MabVax Therapeutics Holdings Inc – History 10
MabVax Therapeutics Holdings Inc – Company Statement 12
MabVax Therapeutics Holdings Inc – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
MabVax Therapeutics Holdings Inc – Business Description 15
MabVax Therapeutics Holdings Inc – SWOT Analysis 16
SWOT Analysis – Overview 16
MabVax Therapeutics Holdings Inc – Strengths 16
MabVax Therapeutics Holdings Inc – Weaknesses 17
MabVax Therapeutics Holdings Inc – Opportunities 18
MabVax Therapeutics Holdings Inc – Threats 19
MabVax Therapeutics Holdings Inc – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
MabVax Therapeutics Holdings Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Aug 03, 2018: Delaware Court of Chancery sets hearing date On petition filed By MabVax Therapeutics 30
Aug 01, 2018: MabVax Therapeutics announces board of director changes 31
Jul 27, 2018: MabVax Therapeutics Files Delaware Petition 32
Jul 05, 2018: MabVax Therapeutics Receives Nasdaq Delist Determination 33
Jun 27, 2018: MabVax Therapeutics Receives Superseding Letter Related to the Late Filing of Form 10-Q 34
May 03, 2018: MabVax Therapeutics Holdings Announces Private Placement Offering 35
Apr 13, 2018: MabVax Therapeutics Receives Continued Listing Deficiency Notice for Nasdaq’s Minimum Stockholders’ Equity Requirements 36
Apr 02, 2018: MabVax Therapeutics Reports 2017 Operational and Financial Results and 2018 Milestones 37
Feb 15, 2018: MabVax Therapeutics Schedules Previously Announced 1-for-3 Reverse Stock Split to Regain Compliance with NASDAQ’s $1.00 Minimum Bid Price Maintenance Requirement 39
Jan 16, 2018: MabVax Therapeutics Holdings Provides Business Strategy Update 40
Section 6 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
MabVax Therapeutics Holdings Inc, Key Facts 6
MabVax Therapeutics Holdings Inc, Key Employees 7
MabVax Therapeutics Holdings Inc, Key Employee Biographies 8
MabVax Therapeutics Holdings Inc, Major Products and Services 9
MabVax Therapeutics Holdings Inc, History 10
MabVax Therapeutics Holdings Inc, Subsidiaries 13
MabVax Therapeutics Holdings Inc, Key Competitors 20
MabVax Therapeutics Holdings Inc, Ratios based on current share price 21
MabVax Therapeutics Holdings Inc, Annual Ratios 22
MabVax Therapeutics Holdings Inc, Annual Ratios (Cont...1) 23
MabVax Therapeutics Holdings Inc, Interim Ratios 25
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
MabVax Therapeutics Holdings Inc, Recent Deals Summary 29
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List of Figures
MabVax Therapeutics Holdings Inc, Performance Chart (2013 - 2017) 24
MabVax Therapeutics Holdings Inc, Ratio Charts 26
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

★海外企業調査レポート[MabVax Therapeutics Holdings Inc (MBVX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medanito SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Medanito SA (Medanito) is an upstream energy company. The company operates in the business of exploration and production of oil and natural gas with participation in the development of unconventional reserves. It operates in the gathering and processing of natural gas liquids (NGL); and gas- …
  • MRI Interventions Inc (MRIC):医療機器:M&Aディール及び事業提携情報
    Summary MRI Interventions Inc (MRI Interventions) is a medical equipment company that develops and commercializes platforms for performing invasive surgical procedures. The company’s products include systems used for performing invasive surgeries on brain and heart. Its products are used for treatin …
  • Albireo Pharma Inc (ALBO)-製薬・医療分野:企業M&A・提携分析
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., is a specialty biopharmaceutical company that focuses on the development and commercialization of innovative bile acid modulators for the treatment of orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and d …
  • Breg Inc:医療機器:M&Aディール及び事業提携情報
    Summary Breg Inc (Breg) is a medical device company that manufactures and distributes sports medicine and rehabilitation products. The company offers products such as knee braces, cold therapy, dvt prophylaxis, hip bracing, shoulder bracing, fracture bracing, elbow wrist bracing, spine bracing, foot …
  • Janssen Pharmaceutica NV:企業のM&A・事業提携・投資動向
    Janssen Pharmaceutica NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Janssen Pharmaceutica NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Emgesa SA ESP-エネルギー分野:企業M&A・提携分析
    Summary Emgesa SA ESP (Emgesa), a subsidiary of Enel, is an energy utility that generates and trades electricity. The company produces power from hydro, coal, and oil and gas; and procures energy from generator and trader agents in the wholesale market. It owns thermal stations: Cartagena and Martin …
  • Catalent Inc:企業の戦略・SWOT・財務情報
    Catalent Inc - Strategy, SWOT and Corporate Finance Report Summary Catalent Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • China Longyuan Power Group Corporation Ltd (916):企業の財務・戦略的SWOT分析
    China Longyuan Power Group Corporation Ltd (916) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Kingsgate Consolidated Limited:企業の戦略・SWOT・財務分析
    Kingsgate Consolidated Limited - Strategy, SWOT and Corporate Finance Report Summary Kingsgate Consolidated Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SRI International-医療機器分野:企業M&A・提携分析
    Summary SRI International (SRI) is a research institute which provides commercial research and development programs. It conducts research and development in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economi …
  • Hays plc (HAS):企業の財務・戦略的SWOT分析
    Hays plc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Credicorp Ltd (BAP):企業の財務・戦略的SWOT分析
    Credicorp Ltd (BAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Hutchison China Meditech Ltd:企業の戦略・SWOT・財務分析
    Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report Summary Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • KDDI Corporation (9433):企業の財務・戦略的SWOT分析
    KDDI Corporation (9433) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • EnergySolutions, Inc.:企業の戦略・SWOT・財務情報
    EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Debiopharm Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Group (Debiopharm) is a biopharmaceutical company that develops biologics and small molecule drug candidates. The company’s product portfolio includes eloxatin, elplat, dacotin, dacplat, decapeptyl, neo decapeptyl, trelstar, pamorelin, salvacyl and moapar, among others. It also of …
  • Fauji Fertilizer Co Ltd (FFC):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Co Ltd (FFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Changmao Biochemical Engineering Co., Ltd:戦略・SWOT・企業財務分析
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Public Power Corporation SA (PPC):電力:M&Aディール及び事業提携情報
    Summary Public Power Corporation SA (PPC) is a vertically integrated electric utility. It generates and supplies electricity. The company produces energy using lignite, gas, oil, hydro, wind and solar sources. PPC owns power generation projects across the country; holds interests in lignite mines in …
  • QinetiQ Group plc:企業のM&A・事業提携・投資動向
    QinetiQ Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's QinetiQ Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆